| | Hang Seng Index | 26.180 HKD | -0.280 | -1.058% | 330.07M | 8.66B | 26.473 (-1.106%) HKD as at 2026/04/22 | | |
| | Hang Seng China Enterprises Index | 89.260 HKD | -0.920 | -1.020% | 54.20M | 4.85B | 90.148 (-0.985%) HKD as at 2026/04/22 | | |
| | Hang Seng TECH Index | 4.750 HKD | -0.108 | -2.223% | 615.02M | 2.94B | 4.955 (-4.128%) HKD as at 2026/04/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 41.040 HKD | -2.180 | -5.044% | 56.80M | 2.40B | 42.806 (-4.124%) HKD as at 2026/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 90.380 HKD | +1.380 | +1.551% | 9.29M | 870.53M | 89.212 (+1.310%) HKD as at 2026/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 3.766 HKD | -0.178 | -4.513% | 224.97M | 857.28M | 3.943 (-4.491%) HKD as at 2026/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.716 HKD | +0.074 | +4.507% | 184.60M | 313.61M | 1.647 (+4.221%) HKD as at 2026/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.855 HKD | -0.145 | -2.417% | 29.05M | 170.79M | 5.985 (-2.170%) HKD as at 2026/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.720 HKD | +0.040 | +2.381% | 79.23M | 135.65M | 1.684 (+2.138%) HKD as at 2026/04/22 | | |
| | Hang Seng TECH Index (net total return version) | 10.190 HKD | -0.260 | -2.488% | 13.20M | 135.37M | 10.634 (-4.171%) HKD as at 2026/04/21 | | |
| | FTSE China A50 Index | 17.140 HKD | -0.120 | -0.695% | 5.51M | 95.04M | 17.184 (-0.254%) HKD as at 2026/04/21 | | |
| | Hang Seng TECH Index | 4.834 HKD | -0.118 | -2.383% | 15.67M | 76.16M | 4.945 (-2.253%) HKD as at 2026/04/22 | | |
| | CSI 300 Index | 56.480 HKD | -0.720 | -1.259% | 1.15M | 65.24M | 56.820 (-0.599%) HKD as at 2026/04/21 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 21.420 HKD | -0.060 | -0.279% | 2.94M | 62.98M | 21.407 (+0.059%) HKD as at 2026/04/22 | | |
| | | 9.655 HKD | -0.010 | -0.103% | 6.39M | 61.68M | 9.657 (-0.023%) HKD as at 2026/04/21 | | |
| | Hang Seng Biotech Index | 14.910 HKD | -0.600 | -3.868% | 3.94M | 59.77M | 15.528 (-3.977%) HKD as at 2026/04/22 | | |
| | London Gold Fixing Price | 3,381.000 HKD | -40.000 | -1.169% | 16.67K | 56.51M | 442.100 (-2.349%) USD as at 2026/04/20 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 29.020 HKD | -0.760 | -2.552% | 1.83M | 53.30M | 29.034 (-0.046%) HKD as at 2026/04/21 | | |
| | FTSE China A50 Index | 15.840 HKD | -0.080 | -0.503% | 3.10M | 49.44M | 15.920 (-0.499%) HKD as at 2026/04/21 | | |
| | | 8.210 HKD | -0.005 | -0.061% | 5.60M | 45.95M | 8.208 (+0.026%) HKD as at 2026/04/21 | | |
| | | 10.430 HKD | -0.080 | -0.761% | 3.13M | 32.67M | 10.552 (-1.152%) HKD as at 2026/04/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 2.892 HKD | -0.014 | -0.482% | 4.82M | 13.88M | 2.951 (-1.986%) HKD as at 2026/04/21 | | |
| | Hang Seng High Dividend Yield Index | 32.520 HKD | -0.160 | -0.490% | 417.30K | 13.59M | 33.048 (-1.597%) HKD as at 2026/04/21 | | |
| | London Gold Fixing Price | 22.200 HKD | -0.300 | -1.333% | 569.19K | 12.66M | 22.434 (-1.042%) HKD as at 2026/04/22 | | |
| | | 7.985 HKD | -0.025 | -0.312% | 1.45M | 11.56M | 8.019 (-0.418%) HKD as at 2026/04/21 | | |
| | FactSet Asia Semiconductor Index (net total return) | 133.100 HKD | -2.500 | -1.844% | 79.60K | 10.69M | 133.255 (-0.116%) HKD as at 2026/04/21 | | |
| | Hang Seng Biotech Index | 3.544 HKD | -0.148 | -4.009% | 2.62M | 9.39M | 3.731 (-5.022%) HKD as at 2026/04/21 | | |
| | Bloomberg APAC High Dividend 40 Net Return Index HKD | 14.830 HKD | -0.130 | -0.869% | 605.80K | 8.99M | 14.774 (+0.378%) HKD as at 2026/04/21 | | |
| | S&P GSCI Crude Oil Multiple Contract 55/30/15 1M/2M/3M (USD) ER Index | 10.170 HKD | +0.395 | +4.041% | 860.30K | 8.68M | 9.815 (+3.620%) HKD as at 2026/04/21 | | |
| | CME CF Bitcoin Reference Rate - Asia Pacific Variant | 9.490 HKD | -0.050 | -0.524% | 674.70K | 6.41M | 9.518 (-0.289%) HKD as at 2026/04/22 | | |